IRVING, Texas, March 29 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. , a research-based, biopharmaceutical and consumer products company, will hold its quarterly conference call to discuss fourth quarter and year-end results on Thursday, March 30, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). Fourth quarter audited financial results will be released earlier the same day.
Investors are invited to listen to the conference call by dialing 866-314-5050 in the US or 617-213-8051 internationally. The pass code is 57275637. The call is also being web cast by CCBN and can be accessed at Carrington’s web site at http://www.carringtonlabs.com .
The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.fulldisclosure.com , Thomson/CCBN’s individual investor portal, powered by StreetEvents . Institutional investors can access the call via Thomson’s password-protected event management site, StreetEvents (http://www.streetevents.com ).
Carrington Laboratories, Inc., is an ISO 9001-certified, research-based biopharmaceutical and consumer products company currently utilizing naturally- occurring polymeric carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactures and markets consumer products under the AloeCeuticals(R) brand and manufactures quality products for other companies. Manufacturing operations comply with cGMP standards. The Company’s DelSite Biotechnologies subsidiary is developing its propriety GelSite(R) technology designed to provide controlled release of peptide and protein-based drugs. Carrington’s technology is protected by more than 130 patents in 26 countries. Select products are honored with the internationally coveted CE mark, recognized by more than 20 countries around the world. For more information, visit http://www.carringtonlabs.com .
Carrington Laboratories, Inc.
CONTACT: Maria Mitchell of Carrington Laboratories, Inc., +1-972-518-1300,or mmitchell@carringtonlabs.com
